Scarica l'app Stockscreener
2.63
26.11%
0.60
Precedente Chiudi:
$2.03
Aprire:
$2.08
Volume 24 ore:
811.31K
Relative Volume:
0.34
Capitalizzazione di mercato:
$3.44M
Reddito:
$9.81M
Utile/perdita netta:
$-26.16M
Rapporto P/E:
-0.0678
EPS:
-38.77
Flusso di cassa netto:
$-17.45M
1 W Prestazione:
-0.78%
1M Prestazione:
+7.56%
6M Prestazione:
-95.97%
1 anno Prestazione:
-98.98%
Intervallo 1D:
$2.04
$2.59
Intervallo di 1 settimana:
$1.87
$2.85
Portata 52W:
$1.87
$303.25
Reshape Lifesciences Inc Stock (RSLS) Company Profile
Nome
Reshape Lifesciences Inc
Settore
Industria
Telefono
949-429-6680
Indirizzo
1001 CALLE AMANECER, SAN CLEMENTE
Confronta RSLS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RSLS
Reshape Lifesciences Inc
|
2.586 | 4.49M | 9.81M | -26.16M | -17.45M | -38.77 |
|
ABT
Abbott Laboratories
|
129.06 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.61 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
376.87 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.09 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.49 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Reshape Lifesciences Inc Borsa (RSLS) Ultime notizie
Vyome Therapeutics Sets Board To Lead Reshape Lifesciences Post-Close; New Entity To Trade As Vyome Holdings Under Ticker Symbol HIND - 富途牛牛
MIT AI Experts Take Control: Inside Vyome's Complete Board Overhaul Before Major NASDAQ Debut - Stock Titan
How ReShape Lifesciences Inc. stock performs during market volatilityFree Portfolio Optimization Guide - newsyoung.net
ReShape Lifesciences shareholders approve merger with Vyome Therapeutics - MSN
ReShape Lifesciences Approves Asset Sale and Merger - TipRanks
ReShape Lifesciences RSLS 2025Q2 Earnings Preview Upside Potential on Strategic Reshape Initiatives - AInvest
ReShape Lifesciences Shareholders Approve Merger with Vyome Therapeutics, Ticker Symbol to Change to HIND - AInvest
ReShape announces shareholder approval of Vyome merger - TipRanks
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics - Business Wire
How does ReShape Lifesciences Inc. generate profit in a changing economyAccess high-quality stock research instantly - Jammu Links News
What are the latest earnings results for ReShape Lifesciences Inc.Navigate the market with precision tools - Jammu Links News
What are analysts’ price targets for ReShape Lifesciences Inc. in the next 12 monthsRapid-fire capital growth - Jammu Links News
Is it the right time to buy ReShape Lifesciences Inc. stockGet real-time alerts on top-performing stocks - Jammu Links News
How strong is ReShape Lifesciences Inc. company’s balance sheetExceptional trading results - Jammu Links News
Is ReShape Lifesciences Inc. a growth stock or a value stockCapitalize on momentum-driven opportunities - Jammu Links News
What is the dividend policy of ReShape Lifesciences Inc. stockUnlock expert trading strategies for growth - Jammu Links News
What are the technical indicators suggesting about ReShape Lifesciences Inc.Accelerated profit realization - Jammu Links News
What are ReShape Lifesciences Inc. company’s key revenue driversSpectacular growth rates - Jammu Links News
When is ReShape Lifesciences Inc. stock expected to show significant growthBuild a winning investment strategy today - Jammu Links News
What institutional investors are buying ReShape Lifesciences Inc. stockAchieve breakthrough financial results - Jammu Links News
Why ReShape Lifesciences Inc. stock attracts strong analyst attentionLow Risk Picks for Daily Trading Released - beatles.ru
ReShape Lifesciences Inc. Pullback Analyzed — Is It Time to ExitAI Forecast for Trending Stocks Indicates Upside - metal.it
ReShape Lifesciences Inc. Forms Double Bottom Pattern — Eyes on BreakoutWatchlist for Smart Swing Trading Updated - metal.it
Published on: 2025-07-29 19:35:19 - metal.it
Options Data Show Bullish Bias in ReShape Lifesciences Inc.Pattern Alert With ROI Driven Strategy Shared - metal.it
ReShape Lifesciences Inc. Inches Toward Key Resistance — Will It BreakReal Trader Watchlist of Hot Stocks Released - metal.it
ReShape Lifesciences Holds Special Stockholder Meeting - TipRanks
ReShape Lifesciences Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - Autocar Professional
What drives ReShape Lifesciences Inc. stock priceTremendous growth potential - PrintWeekIndia
What analysts say about ReShape Lifesciences Inc. stockPhenomenal capital appreciation - Autocar Professional
Will ReShape Lifesciences Inc. stock split in the near futureOverwhelming profit margins - jammulinksnews.com
ReShape Lifesciences Announces Partial Adjournment of Stockholder Meeting for Asset Sale and Charter Amendment Proposals - Nasdaq
ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders - GlobeNewswire
ReShape Lifesciences Merger at Critical Stage: Stockholders Must Approve Asset Sale by August 7 - Stock Titan
Is ReShape Lifesciences Inc. a good long term investmentHigh-profit stock alerts - jammulinksnews.com
Reshape Lifesciences Inc Azioni (RSLS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.59%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):